Journal article icon

Journal article : Review

A data science roadmap for open science organizations engaged in early-stage drug discovery

Abstract:

The Structural Genomics Consortium is an international open science research organization with a focus on accelerating early-stage drug discovery, namely hit discovery and optimization. We, as many others, believe that artificial intelligence (AI) is poised to be a main accelerator in the field. The question is then how to best benefit from recent advances in AI and how to generate, format and disseminate data to enable future breakthroughs in AI-guided drug discovery. We present here the rec...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41467-024-49777-x

Authors


More by this author
Role:
Author
ORCID:
0000-0002-0550-1133
More by this author
Role:
Author
ORCID:
0000-0002-4782-6016
More by this author
Role:
Author
ORCID:
0000-0003-4970-6461
More from this funder
Name:
European Molecular Biology Laboratory
Funder identifier:
https://ror.org/050589e39
Publisher:
Nature Research
Journal:
Nature Communications More from this journal
Volume:
15
Issue:
1
Article number:
5640
Publication date:
2024-07-05
Acceptance date:
2024-06-12
DOI:
EISSN:
2041-1723
ISSN:
2041-1723
Language:
English
Subtype:
Review
Pubs id:
2012893
Local pid:
pubs:2012893
Source identifiers:
2090472
Deposit date:
2024-07-05
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP